Policy regarding weight management medication (tirzepatide, brand name Mounjaro) in Lancashire and South Cumbria

NHS England has provided a national position on the prescribing of weight loss medication and this has now been adopted across Lancashire and South Cumbria.

GPs are now able to prescribe tirzepatides to people who meet the following criteria. These are:

• People with a body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds).
• More than 18 years old.

With at least four of the following long-term conditions:

• Atherosclerotic cardiovascular disease (ASCVD)
• Hypertension
• Dyslipidaemia
• Obstructive sleep apnoea
• Type two diabetes mellitus

Anyone prescribed tirzepatides will also be referred to the Healthier You: Behavioural Support for Obesity Programme. Engagement with the programme is required to continue receiving prescriptions.

People are asked not to contact their GP practice regarding this service. Practices will proactively contact eligible patients.